These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

698 related items for PubMed ID: 24376174

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Increased bactericidal activity of colistin on Pseudomonas aeruginosa biofilms in anaerobic conditions.
    Kolpen M, Appeldorff CF, Brandt S, Mousavi N, Kragh KN, Aydogan S, Uppal HA, Bjarnsholt T, Ciofu O, Høiby N, Jensen PØ.
    Pathog Dis; 2016 Feb; 74(1):ftv086. PubMed ID: 26458402
    [Abstract] [Full Text] [Related]

  • 3. Lack of the Major Multifunctional Catalase KatA in Pseudomonas aeruginosa Accelerates Evolution of Antibiotic Resistance in Ciprofloxacin-Treated Biofilms.
    Ahmed MN, Porse A, Abdelsamad A, Sommer M, Høiby N, Ciofu O.
    Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31307984
    [Abstract] [Full Text] [Related]

  • 4. Bactericidal effect of colistin on planktonic Pseudomonas aeruginosa is independent of hydroxyl radical formation.
    Brochmann RP, Toft A, Ciofu O, Briales A, Kolpen M, Hempel C, Bjarnsholt T, Høiby N, Jensen PØ.
    Int J Antimicrob Agents; 2014 Feb; 43(2):140-7. PubMed ID: 24315789
    [Abstract] [Full Text] [Related]

  • 5. Reinforcement of the bactericidal effect of ciprofloxacin on Pseudomonas aeruginosa biofilm by hyperbaric oxygen treatment.
    Kolpen M, Mousavi N, Sams T, Bjarnsholt T, Ciofu O, Moser C, Kühl M, Høiby N, Jensen PØ.
    Int J Antimicrob Agents; 2016 Feb; 47(2):163-7. PubMed ID: 26774522
    [Abstract] [Full Text] [Related]

  • 6. Hyperbaric Oxygen Sensitizes Anoxic Pseudomonas aeruginosa Biofilm to Ciprofloxacin.
    Kolpen M, Lerche CJ, Kragh KN, Sams T, Koren K, Jensen AS, Line L, Bjarnsholt T, Ciofu O, Moser C, Kühl M, Høiby N, Jensen PØ.
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28874373
    [Abstract] [Full Text] [Related]

  • 7. Activity of Antibiotics against Pseudomonas aeruginosa in an In Vitro Model of Biofilms in the Context of Cystic Fibrosis: Influence of the Culture Medium.
    Diaz Iglesias Y, Van Bambeke F.
    Antimicrob Agents Chemother; 2020 Mar 24; 64(4):. PubMed ID: 32015047
    [Abstract] [Full Text] [Related]

  • 8. Anti-biofilm and resistance suppression activities of CXA-101 against chronic respiratory infection phenotypes of Pseudomonas aeruginosa strain PAO1.
    Riera E, Macià MD, Mena A, Mulet X, Pérez JL, Ge Y, Oliver A.
    J Antimicrob Chemother; 2010 Jul 24; 65(7):1399-404. PubMed ID: 20435779
    [Abstract] [Full Text] [Related]

  • 9. Antibiotic susceptabilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions.
    Hill D, Rose B, Pajkos A, Robinson M, Bye P, Bell S, Elkins M, Thompson B, Macleod C, Aaron SD, Harbour C.
    J Clin Microbiol; 2005 Oct 24; 43(10):5085-90. PubMed ID: 16207967
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Modelling of ciprofloxacin killing enhanced by hyperbaric oxygen treatment in Pseudomonas aeruginosa PAO1 biofilms.
    Gade PAV, Olsen TB, Jensen PØ, Kolpen M, Høiby N, Henneberg KÅ, Sams T.
    PLoS One; 2018 Oct 24; 13(6):e0198909. PubMed ID: 29902223
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Bacteriophage PEV20 and Ciprofloxacin Combination Treatment Enhances Removal of Pseudomonas aeruginosa Biofilm Isolated from Cystic Fibrosis and Wound Patients.
    Chang RYK, Das T, Manos J, Kutter E, Morales S, Chan HK.
    AAPS J; 2019 Apr 04; 21(3):49. PubMed ID: 30949776
    [Abstract] [Full Text] [Related]

  • 15. Analysis of Pseudomonas aeruginosa PAO1 Biofilm Protein Profile After Exposure to n-Butanolic Cyclamen coum Extract Alone and in Combination with Ciprofloxacin.
    Shafiei M, Abdi-Ali A, Shahcheraghi F, Vali H, Shahbani Zahiri H, Akbari Noghabi K.
    Appl Biochem Biotechnol; 2017 Aug 04; 182(4):1444-1457. PubMed ID: 28138928
    [Abstract] [Full Text] [Related]

  • 16. Ambroxol inhibits mucoid conversion of Pseudomonas aeruginosa and contributes to the bactericidal activity of ciprofloxacin against mucoid P. aeruginosa biofilms.
    Wang W, Yu J, He Y, Wang Z, Li F.
    APMIS; 2016 Jul 04; 124(7):611-8. PubMed ID: 27102839
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Incorporation of Farnesol Significantly Increases the Efficacy of Liposomal Ciprofloxacin against Pseudomonas aeruginosa Biofilms in Vitro.
    Bandara HM, Herpin MJ, Kolacny D, Harb A, Romanovicz D, Smyth HD.
    Mol Pharm; 2016 Aug 01; 13(8):2760-70. PubMed ID: 27383205
    [Abstract] [Full Text] [Related]

  • 19. Discrepancy between viable counts and light output as viability measurements, following ciprofloxacin challenge of self-bioluminescent Pseudomonas aeruginosa biofilms.
    Marques CN, Salisbury VC, Greenman J, Bowker KE, Nelson SM.
    J Antimicrob Chemother; 2005 Oct 01; 56(4):665-71. PubMed ID: 16105852
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.